You may be right.

But epigenetic scientific research has been around a long time and seems to have a concentration in cancers. zen3694 is showing promise and more is being understood about it's MOA and which type of patients will respond best, thus allowing for targetting.

My guess is that epigenetics is extremely complex but eventually breakthroughs will happen.

On a separate thought Don is not allowing liquidity and backed off on the NASDAQ listing promises he made years ago. I think the reason is that Don with his incredible abuse of "forward looking statements" would find himself in trouble quickly with tough USA shareholders and the SEC. The SEC would be all over Don with his dishonesty. I've felt for a number of years that Don despises shareholders because they ask for performance and accountability...basic requirements of people who have invested their money in the hopes that the company will succeed.

And now we have a CEO who is afraid to take questions from shareholders. Pathetic really.

GLTA

Toinv